Invention Grant
- Patent Title: Biomarkers of hemorrhagic shock
- Patent Title (中): 出血性休克的生物标志物
-
Application No.: US13696530Application Date: 2011-05-11
-
Publication No.: US09435813B2Publication Date: 2016-09-06
- Inventor: Hasan B. Alam , Yongqing Li
- Applicant: Hasan B. Alam , Yongqing Li
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2011/036067 WO 20110511
- International Announcement: WO2011/143308 WO 20111117
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/15 ; C40B40/10 ; G01N33/92
Abstract:
Methods for the use of keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) (KC/GRO), apolipoprotein A2 (APOA2), angiotensinogen r (AGT), thyroglobulin (TG), disintegrin and metalloproteinase domain-containing protein 17 (ADAM17), anionic trypsin-1 (PRSS1), complement C4 (C4A), zona pellucida sperm-binding protein 1 (ZP1), neuropilin-2 (NRP2), solute carrier family 13 member 2 (SLC13A2), glucagon-like peptide 2 receptor (GLP2R), lipoma high mobility group protein isoform I-C (HMGIC) fusion partner-like protein 4 (LHFPL4), and claudin-3 (CLDN3) as biomarkers for diagnosis and prognosis, and for monitoring the efficacy of treatment, in hemorrhagic shock (HS).
Public/Granted literature
- US20130149713A1 BIOMARKERS OF HEMORRHAGIC SHOCK Public/Granted day:2013-06-13
Information query
IPC分类:
